All Stories

  1. Technology update: dissolvable microneedle patches for vaccine delivery
  2. Dissolving microneedles for intradermal vaccination: manufacture, formulation, and stakeholder considerations
  3. Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity
  4. How can microneedles overcome challenges facing transdermal drug delivery?
  5. Dissolving microneedles: safety considerations and future perspectives
  6. Dissolving Microneedle Delivery of Nanoparticle-Encapsulated Antigen Elicits Efficient Cross-Priming and Th1 Immune Responses by Murine Langerhans Cells
  7. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: Formulation, characterisation and functionalisation with dornase alfa (DNase)
  8. Potential of microneedles in enhancing delivery of photosensitising agents for photodynamic therapy
  9. Considerations in the sterile manufacture of polymeric microneedle arrays
  10. Hydrogel-Forming Microneedles Prepared from “Super Swelling” Polymers Combined with Lyophilised Wafers for Transdermal Drug Delivery
  11. A proposed model membrane and test method for microneedle insertion studies
  12. Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery
  13. Preaggregated Ag Nanoparticles in Dry Swellable Gel Films for Off-the-Shelf Surface-Enhanced Raman Spectroscopy
  14. The role of microneedles for drug and vaccine delivery
  15. Patient safety and beyond: what should we expect from microneedle arrays in the transdermal delivery arena?
  16. Hydrogel-Forming Microneedles Increase in Volume During Swelling in Skin, but Skin Barrier Function Recovery is Unaffected
  17. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs
  18. Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination
  19. Hydrogel-Forming Microneedle Arrays Can Be Effectively Inserted in Skin by Self-Application: A Pilot Study Centred on Pharmacist Intervention and a Patient Information Leaflet
  20. Microneedle-Mediated Minimally Invasive Patient Monitoring
  21. Microneedle/nanoencapsulation-mediated transdermal delivery: Mechanistic insights
  22. A ratiometric fluorescent hydrogel sensor for zinc(ii) based on a two fluorophore approach
  23. Microneedle-Iontophoresis Combinations for Enhanced Transdermal Drug Delivery
  24. Hydrogel‐Forming and Dissolving Microneedles for Enhanced Delivery of Photosensitizers and Precursors
  25. Microneedles for intradermal and transdermal drug delivery
  26. Sadness, identity, and plastic in over-shopping: The interplay of materialism, poor credit management, and emotional buying motives in predicting compulsive buying
  27. Drug Delivery Strategies for Photodynamic Therapy
  28. Vaccine Delivery Using Microneedles
  29. Hydrogel-forming microneedle arrays exhibit antimicrobial properties: Potential for enhanced patient safety
  30. Strategies for enhanced peptide and protein delivery
  31. Influence of Array Interspacing on the Force Required for Successful Microneedle Skin Penetration: Theoretical and Practical Approaches
  32. Skin Dendritic Cell Targeting via Microneedle Arrays Laden with Antigen-Encapsulated Poly-d,l-lactide-co-Glycolide Nanoparticles Induces Efficient Antitumor and Antiviral Immune Responses
  33. Enhanced Antitumor Activity of the Photosensitizer meso-Tetra(N-methyl-4-pyridyl) Porphine Tetra Tosylate through Encapsulation in Antibody-Targeted Chitosan/Alginate Nanoparticles
  34. - Polymer Implants for Intratumoral Drug Delivery and Cancer Therapy
  35. Fast-drying multi-laminate bioadhesive films for transdermal and topical drug delivery
  36. Flux of ionic dyes across microneedle-treated skin: Effect of molecular characteristics
  37. Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium
  38. Microneedle-mediated transdermal bacteriophage delivery
  39. Electrically-responsive anti-adherent hydrogels for photodynamic antimicrobial chemotherapy
  40. Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations
  41. Influence of skin model on in vitro performance of drug-loaded soluble microneedle arrays
  42. Hydrogel‐Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery
  43. Effect of microneedle treatment on the skin permeation of a nanoencapsulated dye
  44. Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro
  45. Microneedle-mediated vaccine delivery: Harnessing cutaneous immunobiology to improve efficacy
  46. Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery
  47. Microneedle‐Mediated Transdermal and Intradermal Drug Delivery
  48. Physical characterisation and component release of poly(vinyl alcohol)–tetrahydroxyborate hydrogels and their applicability as potential topical drug delivery systems
  49. Influence of a pore‐forming agent on swelling, network parameters, and permeability of poly(ethylene glycol)‐crosslinked poly(methyl vinyl ether‐co‐maleic acid) hydrogels: Application in transdermal delivery systems
  50. Corrigendum to “Dried blood spot assay for estimation of metronidazole concentrations in rats and its application in single animal drug pharmacokinetic study” [J. Chromatogr. B 879 (2011) 1713]
  51. The potential for human exposure, direct and indirect, to the suspected carcinogenic triphenylmethane dye Brilliant Green from green paper towels
  52. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy
  53. Microneedle arrays as medical devices for enhanced transdermal drug delivery
  54. Dried blood spot assay for estimation of metronidazole concentrations in rats and its application in single animal drug pharmacokinetic study
  55. Laser-Engineered Dissolving Microneedle Arrays for Transdermal Macromolecular Drug Delivery
  56. Electrically enhanced solute permeation across poly(ethylene glycol)–crosslinked poly(methyl vinyl ether-co-maleic acid) hydrogels: Effect of hydrogel crosslink density and ionic conductivity
  57. Drug and light delivery strategies for photodynamic antimicrobial chemotherapy (PACT) of pulmonary pathogens: A pilot study
  58. Review of Patents on Microneedle Applicators
  59. Sustained release of proteins from a modified vaginal ring device
  60. Microneedle-mediated intradermal nanoparticle delivery: Potential for enhanced local administration of hydrophobic pre-formed photosensitisers
  61. Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution
  62. Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: Assessments by transepidermal water loss
  63. Novel patch-based systems for the localised delivery of ALA-esters
  64. Hexyl Aminolaevulinate Is a More Effective Topical Photosensitiser Precursor than Methyl Aminolaevulinate and 5-Aminolaevulinic Acids When Applied in Equimolar Doses
  65. Microneedle Pre-treatment of Human Skin Improves 5-Aminolevulininc Acid (ALA)- and 5-Aminolevulinic Acid Methyl Ester (MAL)-Induced PpIX Production for Topical Photodynamic Therapy Without Increase in Pain or Erythema
  66. Design, Optimization and Characterisation of Polymeric Microneedle Arrays Prepared by a Novel Laser-Based Micromoulding Technique
  67. Effect of sub-lethal challenge with Photodynamic Antimicrobial Chemotherapy (PACT) on the antibiotic susceptibility of clinical bacterial isolates
  68. Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety
  69. Microporation Techniques for Enhanced Delivery of Therapeutic Agents
  70. Microneedle Arrays Allow Lower Microbial Penetration Than Hypodermic Needles In Vitro
  71. Aminolevulinic acid-loaded Witepsol microparticles manufactured using a spray congealing procedure: implications for topical photodynamic therapy
  72. Delivery of Methylene Blue and meso-tetra (N-methyl-4-pyridyl) porphine tetra tosylate from cross-linked poly(vinyl alcohol) hydrogels: A potential means of photodynamic therapy of infected wounds
  73. Aminolevulinic acid-loaded Witepsol microparticles manufactured using a spray congealing procedure: implications for topical photodynamic therapy
  74. Practical Considerations in the Pharmaceutical Analysis of Methyl and Hexyl Ester Derivatives of 5-Aminolevulinic Acid
  75. Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments
  76. Processing difficulties and instability of carbohydrate microneedle arrays
  77. Drug delivery strategies for photodynamic antimicrobial chemotherapy: From benchtop to clinical practice
  78. Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolevulinic acid from a novel bioadhesive patch system
  79. Investigation of swelling and network parameters of poly(ethylene glycol)-crosslinked poly(methyl vinyl ether-co-maleic acid) hydrogels
  80. Physicochemical characterization of poly(ethylene glycol) plasticized poly(methyl vinyl ether‐co‐maleic acid) films
  81. Influence of formulation factors on PpIX production and photodynamic action of novel ALA‐loaded microparticles
  82. Development and validation of procedures for assessment of competency of non-pharmacists in extemporaneous dispensing
  83. Development and validation of procedures for assessment of competency of non-pharmacists in extemporaneous dispensing
  84. Drug Delivery Systems for Photodynamic Therapy
  85. Microneedle Arrays Permit Enhanced Intradermal Delivery of a Preformed Photosensitizer
  86. Enhanced surface attachment of protein-type targeting ligands to poly(lactide- co -glycolide) nanoparticles using variable expression of polymeric acid functionality
  87. Photosensitiser delivery for photodynamic therapy. Part 2: systemic carrier platforms
  88. Cover story
  89. Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: Potential for enhanced topical photodynamic therapy
  90. Aminolaevulinic acid diffusion characteristics in ‘in vitro’ normal human skin and actinic keratosis: implications for topical photodynamic therapy
  91. Photosensitiser delivery for photodynamic therapy. Part 1: Topical carrier platforms
  92. Antifungal photodynamic therapy
  93. Comparison of a novel spray congealing procedure with emulsion-based methods for the micro-encapsulation of water-soluble drugs in low melting point triglycerides
  94. Influence of solution viscosity and injection protocol on distribution patterns of jet injectors: Application to photodynamic tumour targeting
  95. Microstructured Devices for Transdermal Drug Delivery and Minimally-Invasive Patient Monitoring
  96. Immunocolloidal Targeting of the Endocytotic Siglec-7 Receptor Using Peripheral Attachment of Siglec-7 Antibodies to Poly(Lactide-co-Glycolide) Nanoparticles
  97. Autoradiographic and Scintillation Analysis of 5-Aminolevulinic Acid Permeation Through Epithelialised Tissue: Implications for Topical Photodynamic Therapy of Superficial Gynaecological Neoplasias
  98. Delivery of photosensitisers and light through mucus: Investigations into the potential use of photodynamic therapy for treatment of Pseudomonas aeruginosa cystic fibrosis pulmonary infection
  99. Attitudes of pharmacy students and community pharmacists to numeracy
  100. Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O
  101. Innovative Drug Delivery Strategies for Topical Photodynamic Therapy using Porphyrin Precursors
  102. Formulation and Characterization of Poly(ethylene Glycol)-Based, 5-Aminolevulinic Acid-Loaded Solid-Dosage Forms Intended for Photodynamic and Photodiagnostic Methodologies in the Colorectal Region
  103. Influence of formulation factors on methyl-ALA-induced protoporphyrin IX accumulation in vivo
  104. In vitro phototoxicity of 5-aminolevulinic acid and its methyl ester and the influence of barrier properties on their release from a bioadhesive patch
  105. Topical Bioadhesive Patch Systems Enhance Selectivity of Protoporphyrin IX Accumulation
  106. Design and physicochemical characterisation of a bioadhesive patch for dose-controlled topical delivery of imiquimod
  107. Pharmaceutical analysis of 5-aminolevulinic acid in solution and in tissues
  108. Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure
  109. Stability of 5-aminolevulinic acid in novel non-aqueous gel and patch-type systems intended for topical application
  110. Drug Delivery of Aminolevulinic Acid from Topical Formulations Intended for Photodynamic Therapy¶
  111. Evaluation of a water-soluble bioadhesive patch for photodynamic therapy of vulval lesions
  112. Bioadhesive patch-based delivery of 5-aminolevulinic acid to the nail for photodynamic therapy of onychomycosis
  113. Drug Delivery of Aminolevulinic acid from Topical Formulations Intended for Photodynamic Therapy
  114. Drug Delivery of Aminolevulinic Acid from Topical Formulations Intended for Photodynamic Therapy¶
  115. Analysis of pyrazine 2,5-dipropionic acid in 5-aminolevulinic acid-loaded urological and topical delivery vehicles: methodology and assay validation
  116. Phototoxicity of 5-Aminolevulinic Acid in the HeLa Cell Line as an Indicative Measure of Photodynamic Effect After Topical Administration to Gynecological Lesions of Intraepithelial Form
  117. Evaluation of the penetration of 5‐aminolevulinic acid through basal cell carcinoma: a pilot study
  118. Bioadhesive, non-drug-loaded nanoparticles as modulators of candidal adherence to buccal epithelial cells: a potentially novel prophylaxis for candidosis
  119. Influence of plasticizer type and storage conditions on properties of poly(methyl vinyl ether-co-maleic anhydride) bioadhesive films